Electroporation-mediated delivery of catalytic oligodeoxynucleotides for manipulation of vascular gene expression

1 Division of Pulmonary and Critical Care Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois 60611; and 2 Department of Pharmacology, Physiology, and Therapeutics, University of North Dakota School of Medicine and Health Sciences, Grand Forks, North Dakota 58203 Submit...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of physiology. Heart and circulatory physiology 2003-11, Vol.285 (5), p.H2240-H2247
Hauptverfasser: Nunamaker, Elizabeth A, Zhang, Hai-Ying, Shirasawa, Yuichi, Benoit, Joseph N, Dean, David A
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page H2247
container_issue 5
container_start_page H2240
container_title American journal of physiology. Heart and circulatory physiology
container_volume 285
creator Nunamaker, Elizabeth A
Zhang, Hai-Ying
Shirasawa, Yuichi
Benoit, Joseph N
Dean, David A
description 1 Division of Pulmonary and Critical Care Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois 60611; and 2 Department of Pharmacology, Physiology, and Therapeutics, University of North Dakota School of Medicine and Health Sciences, Grand Forks, North Dakota 58203 Submitted 14 April 2003 ; accepted in final form 18 July 2003 The development of inexpensive and effective approaches to transiently decrease gene expression in vivo would be useful for the study of physiological processes in living animals. DNAzymes are a novel class of DNA oligonucleotides that can catalytically cleave target mRNAs and thereby reduce protein production. However, current methods for their delivery in vivo are limited and inefficient. In this study, we show that electroporation can be used to deliver DNAzymes to the intact mesenteric vasculature of rats. With the use of PKC- as a target, a set of wild-type and mutant control DNAzymes was designed and shown to reduce both PKC- mRNA and protein levels in cultured smooth muscle cells in a specific manner. The wild-type DNAzyme reduced PKC- protein levels by 70% at 24 h in two different cell lines without decreasing the levels of the five other PKC isoforms tested. When delivered to the intact vasculature using electroporation, the DNAzyme reduced PKC- protein levels by >60% without affecting these other PKC isoforms. Electroporation was required for oligonucleotide transfer and was able to deliver the DNAzymes to multiple cell layers in the vessel wall. Protein levels were reduced maximally by 24 h postelectroporation and returned to normal by 48 h. These results suggest that electroporation can be used to deliver DNAzymes and other DNA oligonucleotides to the vasculature in vivo and can decrease gene expression for a window of time that can be used for experimental studies. DNAzyme; protein kinase C- ; transient knockout; gene delivery Address for reprint requests and other correspondence: D. A. Dean, Div. of Pulmonary and Critical Care Medicine, Feinberg School of Medicine, Northwestern Univ., 303 E. Chicago Ave., Tarry 14-707, Chicago, IL 60611 (E-mail: dean{at}northwestern.edu ).
doi_str_mv 10.1152/ajpheart.00350.2003
format Article
fullrecord <record><control><sourceid>proquest_highw</sourceid><recordid>TN_cdi_highwire_physiology_ajpheart_285_5_H2240</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>71285145</sourcerecordid><originalsourceid>FETCH-LOGICAL-c493t-dccd8f6a10077e183bfcd04c7fc6b7cde7a3ad0b956b8d63c601eb10036b86183</originalsourceid><addsrcrecordid>eNp1UU1r3DAQFaWl2ST9BYXiU2_eSJZleSkUSkiaQKCX5CxkaWwraC1Hkjfrf19tdrNJDz0Nw_vQ0zyEvhK8JIQVF_Jx7EH6uMSYMrws0viAFgkpcsLo6iNaYFrRvCKUnaDTEB4xxoxX9DM6IUVdk4LQBXq6sqCid6PzMho35GvQRkbQmQZrNuDnzLWZklHaORqVOWs6p8Ft52FSFlw0GkLWOp-t5WDGyb647DQbGVRafdbBABlsRw8hJOwcfWqlDfDlMM_Qw_XV_eVNfvfn9-3lr7tclSsac62UrttKEow5B1LTplUal4q3qmq40sAllRo3K1Y1ta6oqjCBJrFp2qvEP0M_977j1KRPKRiil1aM3qyln4WTRvyLDKYXnduIssSYcJ4Mvh8MvHuaIESxNkGBtXIANwXB0xUZKVki0j1ReReCh_b4CMFiV5V4rUq8VCV2VSXVt_f53jSHbhLhx57Qm65_Nh7E2M_pgtZ1s7ierL2HbTxapyyCiZuiKLEYdZvUF_9XH_O8U9G_xji94Q</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71285145</pqid></control><display><type>article</type><title>Electroporation-mediated delivery of catalytic oligodeoxynucleotides for manipulation of vascular gene expression</title><source>MEDLINE</source><source>American Physiological Society</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Nunamaker, Elizabeth A ; Zhang, Hai-Ying ; Shirasawa, Yuichi ; Benoit, Joseph N ; Dean, David A</creator><creatorcontrib>Nunamaker, Elizabeth A ; Zhang, Hai-Ying ; Shirasawa, Yuichi ; Benoit, Joseph N ; Dean, David A</creatorcontrib><description>1 Division of Pulmonary and Critical Care Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois 60611; and 2 Department of Pharmacology, Physiology, and Therapeutics, University of North Dakota School of Medicine and Health Sciences, Grand Forks, North Dakota 58203 Submitted 14 April 2003 ; accepted in final form 18 July 2003 The development of inexpensive and effective approaches to transiently decrease gene expression in vivo would be useful for the study of physiological processes in living animals. DNAzymes are a novel class of DNA oligonucleotides that can catalytically cleave target mRNAs and thereby reduce protein production. However, current methods for their delivery in vivo are limited and inefficient. In this study, we show that electroporation can be used to deliver DNAzymes to the intact mesenteric vasculature of rats. With the use of PKC- as a target, a set of wild-type and mutant control DNAzymes was designed and shown to reduce both PKC- mRNA and protein levels in cultured smooth muscle cells in a specific manner. The wild-type DNAzyme reduced PKC- protein levels by 70% at 24 h in two different cell lines without decreasing the levels of the five other PKC isoforms tested. When delivered to the intact vasculature using electroporation, the DNAzyme reduced PKC- protein levels by &gt;60% without affecting these other PKC isoforms. Electroporation was required for oligonucleotide transfer and was able to deliver the DNAzymes to multiple cell layers in the vessel wall. Protein levels were reduced maximally by 24 h postelectroporation and returned to normal by 48 h. These results suggest that electroporation can be used to deliver DNAzymes and other DNA oligonucleotides to the vasculature in vivo and can decrease gene expression for a window of time that can be used for experimental studies. DNAzyme; protein kinase C- ; transient knockout; gene delivery Address for reprint requests and other correspondence: D. A. Dean, Div. of Pulmonary and Critical Care Medicine, Feinberg School of Medicine, Northwestern Univ., 303 E. Chicago Ave., Tarry 14-707, Chicago, IL 60611 (E-mail: dean{at}northwestern.edu ).</description><identifier>ISSN: 0363-6135</identifier><identifier>EISSN: 1522-1539</identifier><identifier>DOI: 10.1152/ajpheart.00350.2003</identifier><identifier>PMID: 12881213</identifier><language>eng</language><publisher>United States</publisher><subject>Cells, Cultured ; DNA, Catalytic - genetics ; Electroporation - methods ; Gene Expression Regulation, Enzymologic ; Humans ; Muscle, Smooth, Vascular - cytology ; Oligodeoxyribonucleotides - pharmacokinetics ; Protein Kinase C - genetics ; Protein Kinase C-epsilon ; Pulmonary Artery - cytology ; RNA, Messenger - genetics ; Transgenes - genetics</subject><ispartof>American journal of physiology. Heart and circulatory physiology, 2003-11, Vol.285 (5), p.H2240-H2247</ispartof><rights>Copyright © 2003 the American Physiological Society 2003</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c493t-dccd8f6a10077e183bfcd04c7fc6b7cde7a3ad0b956b8d63c601eb10036b86183</citedby><cites>FETCH-LOGICAL-c493t-dccd8f6a10077e183bfcd04c7fc6b7cde7a3ad0b956b8d63c601eb10036b86183</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,778,782,883,3028,27911,27912</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12881213$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nunamaker, Elizabeth A</creatorcontrib><creatorcontrib>Zhang, Hai-Ying</creatorcontrib><creatorcontrib>Shirasawa, Yuichi</creatorcontrib><creatorcontrib>Benoit, Joseph N</creatorcontrib><creatorcontrib>Dean, David A</creatorcontrib><title>Electroporation-mediated delivery of catalytic oligodeoxynucleotides for manipulation of vascular gene expression</title><title>American journal of physiology. Heart and circulatory physiology</title><addtitle>Am J Physiol Heart Circ Physiol</addtitle><description>1 Division of Pulmonary and Critical Care Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois 60611; and 2 Department of Pharmacology, Physiology, and Therapeutics, University of North Dakota School of Medicine and Health Sciences, Grand Forks, North Dakota 58203 Submitted 14 April 2003 ; accepted in final form 18 July 2003 The development of inexpensive and effective approaches to transiently decrease gene expression in vivo would be useful for the study of physiological processes in living animals. DNAzymes are a novel class of DNA oligonucleotides that can catalytically cleave target mRNAs and thereby reduce protein production. However, current methods for their delivery in vivo are limited and inefficient. In this study, we show that electroporation can be used to deliver DNAzymes to the intact mesenteric vasculature of rats. With the use of PKC- as a target, a set of wild-type and mutant control DNAzymes was designed and shown to reduce both PKC- mRNA and protein levels in cultured smooth muscle cells in a specific manner. The wild-type DNAzyme reduced PKC- protein levels by 70% at 24 h in two different cell lines without decreasing the levels of the five other PKC isoforms tested. When delivered to the intact vasculature using electroporation, the DNAzyme reduced PKC- protein levels by &gt;60% without affecting these other PKC isoforms. Electroporation was required for oligonucleotide transfer and was able to deliver the DNAzymes to multiple cell layers in the vessel wall. Protein levels were reduced maximally by 24 h postelectroporation and returned to normal by 48 h. These results suggest that electroporation can be used to deliver DNAzymes and other DNA oligonucleotides to the vasculature in vivo and can decrease gene expression for a window of time that can be used for experimental studies. DNAzyme; protein kinase C- ; transient knockout; gene delivery Address for reprint requests and other correspondence: D. A. Dean, Div. of Pulmonary and Critical Care Medicine, Feinberg School of Medicine, Northwestern Univ., 303 E. Chicago Ave., Tarry 14-707, Chicago, IL 60611 (E-mail: dean{at}northwestern.edu ).</description><subject>Cells, Cultured</subject><subject>DNA, Catalytic - genetics</subject><subject>Electroporation - methods</subject><subject>Gene Expression Regulation, Enzymologic</subject><subject>Humans</subject><subject>Muscle, Smooth, Vascular - cytology</subject><subject>Oligodeoxyribonucleotides - pharmacokinetics</subject><subject>Protein Kinase C - genetics</subject><subject>Protein Kinase C-epsilon</subject><subject>Pulmonary Artery - cytology</subject><subject>RNA, Messenger - genetics</subject><subject>Transgenes - genetics</subject><issn>0363-6135</issn><issn>1522-1539</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1UU1r3DAQFaWl2ST9BYXiU2_eSJZleSkUSkiaQKCX5CxkaWwraC1Hkjfrf19tdrNJDz0Nw_vQ0zyEvhK8JIQVF_Jx7EH6uMSYMrws0viAFgkpcsLo6iNaYFrRvCKUnaDTEB4xxoxX9DM6IUVdk4LQBXq6sqCid6PzMho35GvQRkbQmQZrNuDnzLWZklHaORqVOWs6p8Ft52FSFlw0GkLWOp-t5WDGyb647DQbGVRafdbBABlsRw8hJOwcfWqlDfDlMM_Qw_XV_eVNfvfn9-3lr7tclSsac62UrttKEow5B1LTplUal4q3qmq40sAllRo3K1Y1ta6oqjCBJrFp2qvEP0M_977j1KRPKRiil1aM3qyln4WTRvyLDKYXnduIssSYcJ4Mvh8MvHuaIESxNkGBtXIANwXB0xUZKVki0j1ReReCh_b4CMFiV5V4rUq8VCV2VSXVt_f53jSHbhLhx57Qm65_Nh7E2M_pgtZ1s7ierL2HbTxapyyCiZuiKLEYdZvUF_9XH_O8U9G_xji94Q</recordid><startdate>20031101</startdate><enddate>20031101</enddate><creator>Nunamaker, Elizabeth A</creator><creator>Zhang, Hai-Ying</creator><creator>Shirasawa, Yuichi</creator><creator>Benoit, Joseph N</creator><creator>Dean, David A</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20031101</creationdate><title>Electroporation-mediated delivery of catalytic oligodeoxynucleotides for manipulation of vascular gene expression</title><author>Nunamaker, Elizabeth A ; Zhang, Hai-Ying ; Shirasawa, Yuichi ; Benoit, Joseph N ; Dean, David A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c493t-dccd8f6a10077e183bfcd04c7fc6b7cde7a3ad0b956b8d63c601eb10036b86183</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Cells, Cultured</topic><topic>DNA, Catalytic - genetics</topic><topic>Electroporation - methods</topic><topic>Gene Expression Regulation, Enzymologic</topic><topic>Humans</topic><topic>Muscle, Smooth, Vascular - cytology</topic><topic>Oligodeoxyribonucleotides - pharmacokinetics</topic><topic>Protein Kinase C - genetics</topic><topic>Protein Kinase C-epsilon</topic><topic>Pulmonary Artery - cytology</topic><topic>RNA, Messenger - genetics</topic><topic>Transgenes - genetics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nunamaker, Elizabeth A</creatorcontrib><creatorcontrib>Zhang, Hai-Ying</creatorcontrib><creatorcontrib>Shirasawa, Yuichi</creatorcontrib><creatorcontrib>Benoit, Joseph N</creatorcontrib><creatorcontrib>Dean, David A</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>American journal of physiology. Heart and circulatory physiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nunamaker, Elizabeth A</au><au>Zhang, Hai-Ying</au><au>Shirasawa, Yuichi</au><au>Benoit, Joseph N</au><au>Dean, David A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Electroporation-mediated delivery of catalytic oligodeoxynucleotides for manipulation of vascular gene expression</atitle><jtitle>American journal of physiology. Heart and circulatory physiology</jtitle><addtitle>Am J Physiol Heart Circ Physiol</addtitle><date>2003-11-01</date><risdate>2003</risdate><volume>285</volume><issue>5</issue><spage>H2240</spage><epage>H2247</epage><pages>H2240-H2247</pages><issn>0363-6135</issn><eissn>1522-1539</eissn><abstract>1 Division of Pulmonary and Critical Care Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois 60611; and 2 Department of Pharmacology, Physiology, and Therapeutics, University of North Dakota School of Medicine and Health Sciences, Grand Forks, North Dakota 58203 Submitted 14 April 2003 ; accepted in final form 18 July 2003 The development of inexpensive and effective approaches to transiently decrease gene expression in vivo would be useful for the study of physiological processes in living animals. DNAzymes are a novel class of DNA oligonucleotides that can catalytically cleave target mRNAs and thereby reduce protein production. However, current methods for their delivery in vivo are limited and inefficient. In this study, we show that electroporation can be used to deliver DNAzymes to the intact mesenteric vasculature of rats. With the use of PKC- as a target, a set of wild-type and mutant control DNAzymes was designed and shown to reduce both PKC- mRNA and protein levels in cultured smooth muscle cells in a specific manner. The wild-type DNAzyme reduced PKC- protein levels by 70% at 24 h in two different cell lines without decreasing the levels of the five other PKC isoforms tested. When delivered to the intact vasculature using electroporation, the DNAzyme reduced PKC- protein levels by &gt;60% without affecting these other PKC isoforms. Electroporation was required for oligonucleotide transfer and was able to deliver the DNAzymes to multiple cell layers in the vessel wall. Protein levels were reduced maximally by 24 h postelectroporation and returned to normal by 48 h. These results suggest that electroporation can be used to deliver DNAzymes and other DNA oligonucleotides to the vasculature in vivo and can decrease gene expression for a window of time that can be used for experimental studies. DNAzyme; protein kinase C- ; transient knockout; gene delivery Address for reprint requests and other correspondence: D. A. Dean, Div. of Pulmonary and Critical Care Medicine, Feinberg School of Medicine, Northwestern Univ., 303 E. Chicago Ave., Tarry 14-707, Chicago, IL 60611 (E-mail: dean{at}northwestern.edu ).</abstract><cop>United States</cop><pmid>12881213</pmid><doi>10.1152/ajpheart.00350.2003</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0363-6135
ispartof American journal of physiology. Heart and circulatory physiology, 2003-11, Vol.285 (5), p.H2240-H2247
issn 0363-6135
1522-1539
language eng
recordid cdi_highwire_physiology_ajpheart_285_5_H2240
source MEDLINE; American Physiological Society; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects Cells, Cultured
DNA, Catalytic - genetics
Electroporation - methods
Gene Expression Regulation, Enzymologic
Humans
Muscle, Smooth, Vascular - cytology
Oligodeoxyribonucleotides - pharmacokinetics
Protein Kinase C - genetics
Protein Kinase C-epsilon
Pulmonary Artery - cytology
RNA, Messenger - genetics
Transgenes - genetics
title Electroporation-mediated delivery of catalytic oligodeoxynucleotides for manipulation of vascular gene expression
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T05%3A31%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_highw&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Electroporation-mediated%20delivery%20of%20catalytic%20oligodeoxynucleotides%20for%20manipulation%20of%20vascular%20gene%20expression&rft.jtitle=American%20journal%20of%20physiology.%20Heart%20and%20circulatory%20physiology&rft.au=Nunamaker,%20Elizabeth%20A&rft.date=2003-11-01&rft.volume=285&rft.issue=5&rft.spage=H2240&rft.epage=H2247&rft.pages=H2240-H2247&rft.issn=0363-6135&rft.eissn=1522-1539&rft_id=info:doi/10.1152/ajpheart.00350.2003&rft_dat=%3Cproquest_highw%3E71285145%3C/proquest_highw%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=71285145&rft_id=info:pmid/12881213&rfr_iscdi=true